{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:56Z","timestamp":1791262376419,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajg.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:20:04Z","timestamp":1791260404000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methotrexate-induced liver fibrosis in chronic inflammatory diseases: A cross-sectional study in the Tunisian population"],"prefix":"10.1016","author":[{"given":"Sarra","family":"Laabidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Hajlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-517X","authenticated-orcid":false,"given":"Maissa","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayssir Ben","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Tabka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donia","family":"Gouiaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Chtioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaoula","family":"Zouaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Boussaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rekik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Ben","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Serghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Mokni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Labidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Fekih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajg.2026.09.002_bb0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1529-0131(200002)43:2<464::AID-ANR30>3.0.CO;2-U","article-title":"The changing face of rheumatoid arthritis therapy: results of serial surveys","volume":"43","author":"Mikuls","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ajg.2026.09.002_bb0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00042737-200012110-00010","article-title":"6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease","volume":"12","author":"Mat\u00e9-Jim\u00e9nez","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2026.09.002_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3949\/ccjm.54.4.327","article-title":"Methotrexate in the treatment of arthritis and connective tissue diseases","volume":"54","author":"Wilke","year":"1987","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0020","first-page":"756","article-title":"Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation","volume":"74","author":"Heidelbaugh","year":"2006","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.ajg.2026.09.002_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajg.2026.09.002_bb0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9343(05)80060-9","article-title":"Methotrexate and histologic hepatic abnormalities: a meta-analysis","volume":"90","author":"Whiting-O\u2019Keefe","year":"1991","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2340\/0001555572361364","article-title":"Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy","volume":"72","author":"Themido","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.ajg.2026.09.002_bb0040","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study","volume":"53","author":"Laharie","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2026.09.002_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-023-06847-7","article-title":"Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate","volume":"43","author":"Slouma","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.ajg.2026.09.002_bb0050","article-title":"Risk of liver fibrosis in methotrexate-treated patients: a systematic review","volume":"14","author":"Bichenapally","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ajg.2026.09.002_bb0055","article-title":"A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn\u2019s disease receiving methotrexate therapy","volume":"44S","author":"Cervoni","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00365521.2011.647412","article-title":"Evaluation of liver fibrosis by transient elastography (Fibroscan\u00ae) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial","volume":"47","author":"Barbero-Villares","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ajg.2026.09.002_bb0065","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s10067-021-05678-8","article-title":"Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis","volume":"40","author":"Bafna","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajg.2026.09.002_bb0070","unstructured":"Shrestha R, KC S, Thapa P, Pokharel A, Karki N, Jaishi B. Estimation of liver fat by FibroScan in patients with nonalcoholic fatty liver disease. Cureus 13(7):e16414."},{"issue":"3","key":"10.1016\/j.ajg.2026.09.002_bb0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ancard.2018.05.002","article-title":"Use of the EvalObs\u00ae adherence scale in an unselected French population of treated subjects with antihypertensive, hypolipemiants or oral antidiabetics medications: the FLAHS 2017 adherence survey","volume":"67","author":"Girerd","year":"2018","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"1","key":"10.1016\/j.ajg.2026.09.002_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s42358-020-00145-5","article-title":"High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)","volume":"60","author":"Amaral","year":"2020","journal-title":"Advances in rheumatology (London, England)"},{"key":"10.1016\/j.ajg.2026.09.002_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.1964.00280080027006","article-title":"Methotrexate-induced hepatic injury in an adult. A case report","volume":"113","author":"O\u2019rourke","year":"1964","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ajg.2026.09.002_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4093\/dmj.2023.0240","article-title":"Hepatic fibrosis and Cancer: the silent threats of metabolic syndrome","volume":"48","author":"Friedman","year":"2024","journal-title":"Diabetes Metab J"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.55.5.273","article-title":"Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists","volume":"55","author":"Hassan","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ajg.2026.09.002_bb0100","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3899\/jrheum.090482","article-title":"Monitoring methotrexate toxicity in juvenile idiopathic arthritis","volume":"36","author":"Kocharla","year":"2009","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ajg.2026.09.002_bb0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2026.09.002_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2026.09.002_bb0115","first-page":"21","article-title":"Noninvasive methods for assessing liver fibrosis and steatosis","volume":"20","author":"Kazi","year":"2024","journal-title":"Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ajg.2026.09.002_bb0120","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/annrheumdis-2016-210629","article-title":"Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate","volume":"76","author":"Humphreys","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ajg.2026.09.002_bb0125","first-page":"74","article-title":"Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Zonana-Nacach","year":"2008","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.ajg.2026.09.002_bb0130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2022.12.034","article-title":"Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated","volume":"78","author":"Atallah","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2026.09.002_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol (Fayetteville, N.Y.)"},{"issue":"9","key":"10.1016\/j.ajg.2026.09.002_bb0145","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archderm.1989.01670210056007","article-title":"The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment","volume":"125","author":"Newman","year":"1989","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.ajg.2026.09.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194401","article-title":"Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines","volume":"13","author":"Busger Op Vollenbroek","year":"2018","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.ajg.2026.09.002_bb0155","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","article-title":"Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy","volume":"48","author":"Lindsay","year":"2009","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.ajg.2026.09.002_bb0160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/art.20167","article-title":"Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial","volume":"50","author":"Lambert","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ajg.2026.09.002_bb0165","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Cal\u00e8s","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajg.2026.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2026.09.002_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15203","article-title":"Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients","volume":"35","author":"Lee","year":"2022","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.ajg.2026.09.002_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:20:11Z","timestamp":1791260411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S1687197926001152"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.09.002","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate-induced liver fibrosis in chronic inflammatory diseases: A cross-sectional study in the Tunisian population","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}